Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)

  1. 4-HO-MPT (1 revision)
  2. 3 methylcrotonic aciduria (1 revision)
  3. 5-MeO-DMT (1 revision)
  4. 40S ribosomal protein S19 (1 revision)
  5. 5-HT receptor (1 revision)
  6. 60S ribosomal protein L13 (1 revision)
  7. 3-Methylglutaconyl CoA (1 revision)
  8. "sandbox:FZ" (1 revision)
  9. "sandbox:JDS" (1 revision)
  10. "sandbox:M.S" (1 revision)
  11. 40S ribosomal protein S13 (1 revision)
  12. 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
  13. "sandbox:S.I" (1 revision)
  14. 60S ribosomal protein L10 (1 revision)
  15. "sandbox:WA" (1 revision)
  16. 5q- syndrome (1 revision)
  17. "template:A.M" (1 revision)
  18. "template:A.R" (1 revision)
  19. "template:AM" (1 revision)
  20. "template:AMS" (1 revision)
  21. 3 hydroxyisobutyric aciduria (1 revision)
  22. "template:ArashM" (1 revision)
  23. "template:CA" (1 revision)
  24. "template:F.K" (1 revision)
  25. "template:FI" (1 revision)
  26. "template:Fereshteh karegar (1 revision)
  27. 5-alpha-reductase deficiency surgery (1 revision)
  28. 60S ribosomal protein L15 (1 revision)
  29. 6-Pyruvoyltetrahydropterin synthase deficiency (1 revision)
  30. 60S ribosomal protein L23a (1 revision)
  31. "template:S.C" (1 revision)
  32. "template:Saba Iqbal" (1 revision)
  33. "template:Saba Iqbal.awan" (1 revision)
  34. "template:W.A" (1 revision)
  35. "template:WA" (1 revision)
  36. 310 helix (1 revision)
  37. '''Dr.Prof. Mohammed Abdulwahab AlKhateeb''' -- MD.,FICMS.,-CHIEF CONSULTATNT IN GENERAL INTERNAL MEDICINE, CARDIOLOGY & HEPATOBILIARY DISEASES (1 revision)
  38. 40S ribosomal protein S26 (1 revision)
  39. ''sandbox:M.S" (1 revision)
  40. 5,6-MDO-DiPT (1 revision)
  41. 'Lab Lemco' powder (1 revision)
  42. (-)-1-Phenyl-2-propylaminopentane (1 revision)
  43. 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
  44. (-)-2β-Carbomethoxy-3β-phenyltropane (1 revision)
  45. (-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate (1 revision)
  46. 3c syndrome (1 revision)
  47. 5,6-MeO-MiPT (1 revision)
  48. 5-MeO-DET (1 revision)
  49. 4-Aminobiphenyl (1 revision)
  50. 5-Methoxy-diisopropyltryptamine (1 revision)
  51. 5-MeO-MiPT (1 revision)
  52. 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
  53. -omics (1 revision)
  54. 0-0-1-3 (1 revision)
  55. 0-3 (1 revision)
  56. 1,1'-Bi-2-naphthol (1 revision)
  57. 1,1'-bi-2-naphthol (1 revision)
  58. 1,1,2,2-Tetrachloroethane (1 revision)
  59. 1,1,2-Trichloroethane (1 revision)
  60. 1,2-Dichloroethane (1 revision)
  61. 1,2-rearrangement (1 revision)
  62. 1,3-Bisphosphoglycerate (1 revision)
  63. 1,3-Butadiene (1 revision)
  64. 1,3-Dipolar cycloaddition (1 revision)
  65. 4-HO-MET (1 revision)
  66. 4-HO-DBT (1 revision)
  67. 4-HO-DET (1 revision)
  68. 1,4-Dichlorobenzene (1 revision)
  69. 1,4-Dioxane (1 revision)
  70. 1,5-Pentanediol (1 revision)
  71. 1,8-Bis(dimethylamino)naphthalene (1 revision)
  72. 1,8-Diazabicycloundec-7-ene (1 revision)
  73. 1-(3-Chlorophenyl)piperazine (1 revision)
  74. 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
  75. 100% English (1 revision)
  76. 108 form Wu family T'ai Chi Ch'uan (1 revision)
  77. 11-Hydroxy-THC (1 revision)
  78. 40S ribosomal protein S24 (1 revision)
  79. 40S ribosomal protein S15a (1 revision)
  80. 40S ribosomal protein S5 (1 revision)
  81. 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
  82. 2C-D (1 revision)
  83. 5-MeO-AET (1 revision)
  84. 5-MeS-DMT (1 revision)
  85. 5' flanking region (1 revision)
  86. 5,6-MDO-DMT (1 revision)
  87. 4-Aminoquinoline (1 revision)
  88. 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
  89. Ф29 phage (1 revision)
  90. 3T3-L1 (1 revision)
  91. 4-Dimethylaminophenol (1 revision)
  92. 60S ribosomal protein L32 (1 revision)
  93. 3-Quinuclidinyl benzilate (1 revision)
  94. 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
  95. 4-Methylthioamphetamine (1 revision)
  96. 40S ribosomal protein S7 (1 revision)
  97. 3m syndrome (1 revision)
  98. 23andMe (1 revision)
  99. 3,4-Dimethylamphetamine (1 revision)
  100. 2nd Skin (1 revision)
  101. 60S ribosomal protein L17 (1 revision)
  102. 4-Nitroaniline (1 revision)
  103. 13q deletion syndrome (1 revision)
  104. 5-alpha-reductase deficiency secondary prevention (1 revision)
  105. 5-alpha-reductase deficiency primary prevention (1 revision)
  106. 5-alpha-reductase deficiency electrocardiogram (1 revision)
  107. 24-Dehydrocholesterol reductase (1 revision)
  108. 5150 (Involuntary psychiatric hold) (1 revision)
  109. 16S ribosomal RNA (1 revision)
  110. 2C-T-7 (1 revision)
  111. 4-Androstene-3,6,17-trione (1 revision)
  112. 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
  113. 60S ribosomal protein L12 (1 revision)
  114. 60S ribosomal protein L11 (1 revision)
  115. 3-hydroxyisobutyrate dehydrogenase (1 revision)
  116. 2C-I (1 revision)
  117. 5-hydroxytryptophan (1 revision)
  118. 60S ribosomal protein L19 (1 revision)
  119. 40S ribosomal protein S4, Y isoform 2 (1 revision)
  120. 5-MeO-pyr-T (1 revision)
  121. 60S ribosomal protein L30 (1 revision)
  122. 4-MeO-MiPT (1 revision)
  123. 40S ribosomal protein S14 (1 revision)
  124. 60S ribosomal protein L36a (1 revision)
  125. 4-Hydroxytestosterone (1 revision)
  126. 3C-P (1 revision)
  127. 2C-TFM (1 revision)
  128. 3-methylglutaconic acid (1 revision)
  129. 3-Hydroxyacyl ACP dehydrase (1 revision)
  130. 60S ribosomal protein L23 (1 revision)
  131. 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
  132. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
  133. 40S (1 revision)
  134. 40S ribosomal protein S11 (1 revision)
  135. 5-Methylindole (1 revision)
  136. 2C-B-BZP (1 revision)
  137. 2R hypothesis (1 revision)
  138. 40S ribosomal protein S23 (1 revision)
  139. 2C-B (1 revision)
  140. 4-HO-pyr-T (1 revision)
  141. 2b3a (1 revision)
  142. 40S ribosomal protein S4, Y isoform 1 (1 revision)
  143. 40S ribosomal protein S18 (1 revision)
  144. 17-beta-hydroxysteroid dehydrogenase deficiency x ray (1 revision)
  145. 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
  146. 4-Oxalocrotonate tautomerase (1 revision)
  147. 4-HO-DiPT (1 revision)
  148. 40S ribosomal protein S3 (1 revision)
  149. 454 Life Sciences (1 revision)
  150. 40S ribosomal protein S12 (1 revision)
  151. 4-Methylbenzylidene camphor (1 revision)
  152. 3-Aminoisobutyric acid (1 revision)
  153. 60S ribosomal protein L27a (1 revision)
  154. 5,6-MDO-MiPT (1 revision)
  155. 4-HO-DPT (1 revision)
  156. 4-MTA (1 revision)
  157. 5'-phosphoribosyl-5-aminoimidazole (1 revision)
  158. 2C-B-FLY (1 revision)
  159. 40S ribosomal protein S9 (1 revision)
  160. 5-Hydroxyindoleacetic acid (1 revision)
  161. 60S ribosomal protein L26 (1 revision)
  162. 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
  163. 3-Aminopyridine (1 revision)
  164. 5-MeO-DPT (1 revision)
  165. 4-Hydroxy-4-methylpentanoic acid (1 revision)
  166. 40S ribosomal protein S8 (1 revision)
  167. 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
  168. 5'-3' exoribonuclease 1 (1 revision)
  169. 18-Methoxycoronaridine (1 revision)
  170. 18S ribosomal RNA (1 revision)
  171. 5'-Phosphoribosylformylglycinamidine (1 revision)
  172. 1993 Clinton health care plan (1 revision)
  173. 1998 Klang Valley water crisis (1 revision)
  174. 1 E-10 m (1 revision)
  175. 1 E-11 m (1 revision)
  176. 1 E7 s (1 revision)
  177. 1p36 deletion syndrome (1 revision)
  178. 5,10-Methylenetetrahydrofolate (1 revision)
  179. 2,2,2-Trichloroethanol (1 revision)
  180. 2,2,4-Trimethylpentane (1 revision)
  181. 2,3,4,5-Tetramethoxyamphetamine (1 revision)
  182. 2,3-Bisphosphoglycerate (1 revision)
  183. 2,3-Dihydropyran (1 revision)
  184. 2,3-Dihydroxy-3-methylpentanoic acid (1 revision)
  185. 2,3-squalene oxide (1 revision)
  186. 2,4,5-Trichlorophenoxyacetic acid (1 revision)
  187. 4,5-MDO-DMT (1 revision)
  188. 4,5-MDO-DiPT (1 revision)
  189. 2,4-Dichlorophenol (1 revision)
  190. 2,4-Dinitrophenol (1 revision)
  191. 5-Hydroxytryptophan (1 revision)
  192. 4-Acetoxy-DIPT (1 revision)
  193. 4-Acetoxy-DET (1 revision)
  194. 2,4 Dienoyl-CoA reductase deficiency (1 revision)
  195. 5-MeO-DALT (1 revision)
  196. 2,5-Dimethoxy-4-ethylamphetamine (1 revision)
  197. 2,5-Dimethoxy-4-iodoamphetamine (1 revision)
  198. 3,4-Diaminopyridine (1 revision)
  199. 2,5-Dimethoxy-4-nitroamphetamine (1 revision)
  200. 2,5-Dimethoxyphenethylamine (1 revision)
  201. 2,5-Dimethylfuran (1 revision)
  202. 60S ribosomal protein L35a (1 revision)
  203. 5-MeO-NMT (1 revision)
  204. 5-Methylcytosine (1 revision)
  205. 22q11.2 deletion syndrome case study one (1 revision)
  206. 2-Acetylaminofluorene (1 revision)
  207. 2-Aminoethoxydiphenyl borate (1 revision)
  208. 2-Aminomuconic acid (1 revision)
  209. 5-alpha-reductase deficiency case study one (1 revision)
  210. 5-Lipoxygenase activating protein (1 revision)
  211. 5-Methyltetrahydrofolate (1 revision)
  212. 5-alpha-reductase deficiency future or investigational therapies (1 revision)
  213. 2-Bromopropane (1 revision)
  214. 2-Butyl-3-(p-tolyl)quinuclidine (1 revision)
  215. 2-Chlorophenol (1 revision)
  216. 2-Ethylhexanol (1 revision)
  217. 5-bromouracil (1 revision)
  218. 2-Hydroxyglutaricaciduria (1 revision)
  219. 2-Iodoxybenzoic acid (1 revision)
  220. 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene (1 revision)
  221. 2-Me-DET (1 revision)
  222. 2-Methyl-2-nitrosopropane (1 revision)
  223. 2-Methyl-3,3-diphenyl-3-propanolamine (1 revision)
  224. 2-Methyl-4-Chlorophenoxyacetic Acid (1 revision)
  225. 2-Methylbutyryl-CoA (1 revision)
  226. 2-Methylbutyryl-CoA dehydrogenase deficiency (1 revision)
  227. 2-Nitropropane (1 revision)
  228. 2-Nonenal (1 revision)
  229. 60S ribosomal protein L10-like (1 revision)
  230. 2-Phenylphenol (1 revision)
  231. 2-Pyridone (1 revision)
  232. 2-Pyrone (1 revision)
  233. 2-chloroethanol (1 revision)
  234. 2-hydroxyphytanoyl-CoA lyase (1 revision)
  235. 60S ribosomal protein L14 (1 revision)
  236. 2-propanoyl-3-(4-isopropylphenyl)-tropane (1 revision)
  237. 60S ribosomal protein L18 (1 revision)
  238. 60S ribosomal protein L21 (1 revision)
  239. 60S ribosomal protein L18a (1 revision)
  240. 2007 WikiDoc Foundation Scholars (1 revision)
  241. 40S ribosomal protein S28 (1 revision)
  242. 60S ribosomal protein L24 (1 revision)
  243. 60S ribosomal protein L39 (1 revision)
  244. 60S ribosomal protein L28 (1 revision)
  245. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (1 revision)
  246. 3-Ureidopropionic acid (1 revision)
  247. 60S ribosomal protein L29 (1 revision)
  248. 21-Hydroxylase Deficiency (patient information) (1 revision)
  249. 60S ribosomal protein L37a (1 revision)
  250. 60S ribosomal protein L37 (1 revision)

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)